All In Biotech

Drug Trial Radar · NCT06989437

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

A Phase 2b/3, Randomized, Double-Blind Study to Investigate the Efficacy, Safety, and Tolerability of Ponsegromab (PF-06946860) Compared With Placebo Both With Background First-Line Chemotherapy in Adult Participants With Cachexia and Metastatic Pancreatic Ductal Adenocarcinoma

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 982 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

982

Planned (sponsor's estimate)

Start

Oct 3, 2025

Primary completion

Jan 23, 2028

Study completion Dec 24, 2029

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 25, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic ductal adenocardinoma.

Conditions

  • Cachexia
  • Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

  • ponsegromabDrug

    Double-Blind ponsegromab Treatment

  • placeboDrug

    Double-Blind placebo Treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change from baseline in body weight for ponsegromab compared to placeboTime frame: Baseline, Week 12
  2. Change from baseline in Functional Assessment of Anorexia/Cachexia Therapy 5-item Anorexia Symptom Scale scoresTime frame: Baseline, Week 12

Locations

230 sites in 21 countries. Site status is shown where the registry gives one.

  • The Kirklin Clinic of UAB Hospital

    Birmingham, Alabama · Recruiting

  • The University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Mayo Clinic Hospital

    Phoenix, Arizona · Recruiting

  • Central Arkansas Radiation Therapy Institute, dba CARTI

    Bryant, Arkansas · Recruiting

  • Central Arkansas Radiation Therapy Institute, dba CARTI

    Conway, Arkansas · Recruiting

  • CARTI Cancer Center

    Little Rock, Arkansas · Recruiting

  • Central Arkansas Radiation Therapy Institute, dba CARTI

    North Little Rock, Arkansas · Recruiting

  • Central Arkansas Radiation Therapy Institute, dba CARTI

    Pine Bluff, Arkansas · Recruiting

  • UC San Diego Medical Center - Encinitas

    Encinitas, California · Recruiting

  • Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • UCI Health - Irvine

    Irvine, California · Recruiting

  • UC San Diego Koman Family Outpatient Pavilion

    La Jolla, California · Recruiting

  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion)

    La Jolla, California · Recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • UC San Diego Sulpizio Cardiovascular Center

    La Jolla, California · Recruiting

  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • UCLA Department of Medicine - Hematology/Oncology

    Los Angeles, California · Recruiting

  • UC Irvine Health

    Orange, California · Recruiting

  • UC San Diego Medical Center - Bankers Hill

    San Diego, California · Recruiting

  • UC San Diego McGrath Outpatient Pavilion - Hillcrest

    San Diego, California · Recruiting

  • UC San Diego Medical Center - Hillcrest

    San Diego, California · Recruiting

  • UC San Diego Medical Center - Rancho Bernardo

    San Diego, California · Recruiting

  • UCLA Hematology/Oncology - Santa Monica

    Santa Monica, California · Recruiting

  • Providence Medical Foundation

    Santa Rosa, California · Recruiting

  • UC San Diego Medical Center - Vista

    Vista, California · Recruiting

  • Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy

    Washington D.C., District of Columbia · Recruiting

  • Georgetown University Medical Center

    Washington D.C., District of Columbia · Recruiting

  • Mayo Clinic Pharmacy

    Jacksonville, Florida · Recruiting

  • Mayo Clinic

    Jacksonville, Florida · Recruiting

  • University Cancer & Blood Center, LLC

    Athens, Georgia · Recruiting

  • Cardiology Associates, Inc

    ‘Aiea, Hawaii · Recruiting

  • Invision, LLC

    Honolulu, Hawaii · Recruiting

  • University of Hawaii Cancer Center

    Honolulu, Hawaii · Recruiting

  • Cancer Care Specialists of Illinois

    Decatur, Illinois · Recruiting

  • Decatur Memorial Hospital

    Decatur, Illinois · Recruiting

  • Hope and Healing Clinical Research LLC

    Hinsdale, Illinois · Recruiting

  • Hope and Healing Clinical Research LLC New Lenox- Research Department

    New Lenox, Illinois · Recruiting

  • Cancer Care Specialists of Illinois - Cancer Care Center of O'Fallon

    O'Fallon, Illinois · Recruiting

  • United Imaging Consultants

    Lenexa, Kansas · Recruiting

  • MidAmerica Cancer Care- American Oncology Partners

    Merriam, Kansas · Recruiting

Showing 40 of 230 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.